SYSTEMIC LUPUS ERTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody therapy aims to tame lupus in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called budoprutug in 30 adults with active lupus who haven't responded well to standard treatments. The drug targets and depletes certain immune cells (B cells) to help control the disease. The main goals are to check safety and how the bod…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New blood test method could spot autoimmune diseases earlier
Knowledge-focused Not yet recruitingThis study will use a high-tech blood test (mass spectrometry) to look at different immune cells in 500 people with various autoimmune diseases like lupus, rheumatoid arthritis, and Sjogren's syndrome, plus healthy volunteers. The goal is to find patterns that could help doctors …
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC